1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Bone marrow recovery by morphometry during induction chemotherapy for acute lymphoblastic leukemia in childrenNguyen, T.; Melville, A.; Nath, S.; Story, C.; Howell, S.; Sutton, R.; Zannettino, A.; Revesz, T.; Bandapalli, O.
2014Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia - prospective open cohort analyses of the ALLR3 trialMasurekar, A.; Parker, C.; Shanyinde, M.; Moorman, A.; Hancock, J.; Sutton, R.; Ancliff, P.; Morgan, M.; Goulden, N.; Fraser, C.; Hoogerbrugge, P.; Revesz, T.; Darbyshire, P.; Krishnan, S.; Love, S.; Saha, V.; Baer, M.
2010Chemokine/Chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7Faaij, C.; Willemze, A.; Revesz, T.; Balzarolo, M.; Tensen, C.; Hoogeboom, M.; Vermeer, M.; van Wering, E.; Zwaan, C.; Kaspers, G.; Story, C.; van Halteren, A.; Vossen, J.; Egeler, R.; van Tol, M.; Annels, N.
2010Bone marrow fibrosis and vascular density lack prognostic significance in childhood acute lymphoblastic leukaemiaBaros, A.; de Jong, A.; Manton, N.; Venn, N.; Story, C.; Hodge, G.; Nath, S.; Suppiah, R.; Tapp, H.; Sutton, R.; Revesz, T.
2010Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-lable randomised trialParker, C.; Waters, R.; Leighton, C.; Hancock, J.; Sutton, R.; Moorman, A.; Ancliff, P.; Morgan, M.; Masurekar, A.; Goulden, N.; Green, N.; Revesz, T.; Darbyshire, P.; Love, S.; Saha, V.
2010Increased thrombophilic tendency in pediatric cystic fibrosis patientsWilliams, V.; Griffiths, A.; Yap, Z.; Martin, J.; Smith, G.; Couper, R.; Revesz, T.
2016Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemiaIrving, J.; Enshaei, A.; Parker, C.; Sutton, R.; Kuiper, R.; Erhorn, A.; Minto, L.; Venn, N.; Law, T.; Yu, J.; Schwab, C.; Davies, R.; Matheson, E.; Davies, A.; Sonneveld, E.; Den Boer, M.; Love, S.; Harrison, C.; Hoogerbrugge, P.; Revesz, T.; et al.
2013Implementation of a hospital oral care protocol and recording of oral mucositis in children receiving cancer treatment: a retrospective and a prospective studyQutob, A.; Allen, G.; Gue, S.; Revesz, T.; Logan, R.; Keefe, D.
2017High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatmentHeatley, S.L.; Sadras, T.; Kok, C.H.; Nievergall, E.; Quek, K.; Dang, P.; McClure, B.; Venn, N.; Moore, S.; Suttle, J.; Law, T.; Ng, A.; Muskovic, W.; Norris, M.D.; Revesz, T.; Osborn, M.; Moore, A.S.; Suppiah, R.; Fraser, C.; Alvaro, F.; et al.
2014The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trialMasurekar, A.; Fong, C.; Hussein, A.; Revesz, T.; Hoogerbrugge, P.; Love, S.; Ciria, C.; Parker, C.; Krishnan, S.; Saha, V.

Discover